Involvement of the renal kallikrein-kinin system in K+-induced diuresis and natriuresis in anesthetized rats

European Journal of Pharmacology

Volumn 399, Issue 2-3, 2000, Pages 223-227

  Suzuki, Tatsunori ^a   Katori, Makoto ^a   Fujita, Tomoe ^a   Kumagai, Yuji ^a   Majima, Masataka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bradykinin B2 receptor antagonist; Diuresis; FR173657; K+; Kallikrein secretion; Natriuresis

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; BRADYKININ B2 RECEPTOR; POTASSIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIURESIS; KALLIKREIN URINE LEVEL; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION; URINE VOLUME;

ANESTHESIA; ANIMALS; CHLORIDES; DIURESIS; INFUSIONS, INTRAVENOUS; KALLIKREIN-KININ SYSTEM; KALLIKREINS; KIDNEY; MALE; NATRIURESIS; POTASSIUM; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; TIME FACTORS; URINATION;

EID: 0034617447     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00382-4     Document Type: Article

References (21)

1. Aramori I., Zenkoh J., Morikawa N., O'Donnell N., Asano M., Nakamura K., Iwami M., Kojo H., Notsu Y. Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657. Mol. Pharmacol. 51:1997;171-176.
2. 2 receptor antagonist, FR173657. Br. J. Pharmacol. 120:1997;617-624.
3. Barden A.E., Beilin L.J., Vandogen R. Effect of potassium supplementation on blood pressure and vasodilator mechanisms in spontaneously hypertensive rats. Clin. Sci. 75:1988;527-534.
4. Berry T.D., Hasstedt S.J., Hunt S.C., Wu L.L., Smith J.B., Ash K.O., Kuida H., Williams R.R. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension. 13:1989;3-8.
5. Figueroa C.D., Caorsi I., Subiabre J., Vio C.P. Immunoreactive kallikrein localization in the rat kidney. J. Histochem. Cytochem. 32:1984;117-121.
6. Fujita T., Sato Y. Natriuretic and antihypertensive effects of potassium in DOCA-salt hypertensive rats. Kidney Int. 24:1983;731-739.
7. Fujita T., Hayashi I., Kumagai Y., Inamura N., Majima M. Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats. Br. J. Pharmacol. 128:1999;1275-1283.
8. Hayashi I., Fujita T., Majima M., Katori M. A secretory mechanism of renal kallikrein by a high potassium ion; a possible involvement of ATP-sensitive potassium channel. Immunopharmacology. 44:1999;49-55.
9. Hunt C.S., Hasstedt S.J., Wu L.L., Williams R.R. A gene-environment interaction between inferred kallikrein genotype and potassium. Hypertension. 22:1993;161-168.
10. Ito H., Majima M., Nakajima S., Hayashi I., Katori M., Izumi T. Effect of prolonged administration of a urinary kininase inhibitor, ebelactone B on the development of deoxycorticosterone acetate-salt hypertension in rats. Br. J. Pharmacol. 126:1999;613-620.
11. 2 receptor in SHR. Am. J. Physiol. 45:1999;F476-F484.
12. Majima M., Katori M. Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system. Trends Pharmacol. Sci. 16:1995;239-246.
13. 2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy. Br. J. Pharmacol. 121:1997;723-730.
14. Margaret J., Defronzo R.A. Extrarenal potassium homeostasis. Am. J. Physiol. 240:1981;F257-F268.
15. 2 receptor antagonist increases chloride and water absorption in rat medullary collecting duct. Am. J. Physiol. 271:1996;R352-R360.
16. Nishimura K., Alhenc-Gelas F., White A., Erdos E.G. Activation of membrane-bound kallikrein and renin in the kidney. Proc. Natl. Acad. Sci. U. S. A. 77:1980;4975-4978.
17. Smith S.R., Klotman P.E., Svetky L.P. Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension. J. Am. Soc. Nephrol. 2:1992;1302-1309.
18. Suzuki H., Kondo K., Saruta T. Effect of potassium chloride on blood pressure in two kidney, one clip Goldblatt hypertensive rats. Hypertension. 3:1981;566-573.
19. Svetkey L.P., Yarger W.E., Feusner J.R., Delong E., Klotman P.E. Double blind, placebo controlled trial of potassium chloride in the treatment of mild hypertension. Hypertension. 9:1987;444-450.
20. Tomita K., Pisano J.J., Knepper M.A. Control of sodium and potassium transport in the cortical collecting duct of the rat. J. Clin. Invest. 76:1985;132-136.
21. Valdes G., Vio C.P., Montero J., Aavendano R. Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives. J. Hum. Hypertens. 5:1991;91-96.